8-K current report · filed Jul 22, 2026

Becton Dickinson (BDX) 8-K Current Report: July 22, 2026

Item 5.02Item 7.01BDX overview

Short answer

Becton Dickinson (BDX) filed an 8-K current report with the SEC on July 22, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Michael D. Garrison retiring from executive vice president and segment president role.

Becton Dickinson 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Michael D. Garrison retiring from executive vice president and segment president role
  • Departure effective after fiscal year-end, providing transition continuity
  • Search underway for next Medical Essentials segment president
  • BioPharma Systems to report directly to CEO Thomas E. Polen
  • Reporting change streamlines operating structure but increases CEO oversight requirements

Item 7.01 · Regulation FD Disclosure

  • BD’s July 22, 2026 press release announces matters described under Item 5.02, likely involving officer or director changes
  • Exhibit 99.1 contains the substantive disclosure and should be reviewed for succession, compensation, and governance implications

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Becton Dickinson 8-K filings

Get the next BDX 8-K as it lands

Follow BDX for push alerts, or ask the research agent what this filing means.